However, from a public health perspective, the relevant question is not what results one would obtain if smokers were forced to use a particular strategy, but what results are obtained when smokers make the choice to use a particular strategy. This is why Stan Glantz's approach is inappropriate.

Today, I discuss the reasons why hiding a conflict of interest like this is problematic.

The Rest of the Story

Moreover, the ingredients of electronic cigarettes are well known. Even the components of electronic cigarette vapor have been well characterized. In fact, we know a lot more about the components of electronic cigarette vapor than we do about those of cigarette smoke.

Ironically, in the long run, hiding the influence of Big Pharma on smoking cessation policy does not advance the cessation field, but brings it to a grinding halt. The public, and tobacco control practitioners themselves, need to understand the deeply ingrained roots of Big Pharma within the tobacco control movement, especially in the smoking cessation field. Failure to do so will lead to blind following of an industry-based agenda. This is precisely what has happened in tobacco control.

LAST：2014 Hangsen new e-cigarette model C5R PRO ego ce7 clearomizer with 900mah improved ego/echo version battery |NEXT：2012 Mega eGO Cartomizer with xpower eGo battery -- ego K e cigarette